Healthcare >> CEO Interviews >> August 3, 2000
DR. COLIN GODDARD was appointed President and Chief Executive Officer of
OSI in October 1998, having previously served with the company as
President since August 1997, Executive Vice President and Chief
Operating Officer (1996 to 1997), Vice President Research Operations
(1993 to 1996), Director of Drug Discovery (1992 to 1993) and Program
Manager, Drug Discovery (1991 to 1992). Dr. Goddard joined the company
as a scientist in January 1989. Dr. Goddard was responsible for the
development of OSI's pioneering robotic high throughput screening
operation in the early 1990s and was instrumental in the development of
the company's fully integrated drug discovery strategy. Before joining
OSI, Dr. Goddard spent four years at the National Cancer Institute in
Bethesda, Maryland, conducting research on the src Oncogene. Dr. Goddard
trained as a cancer pharmacologist in Birmingham, UK, receiving his PhD
from the University of Aston in 1985. Profile
Pharmaceuticals?
Dr. Goddard: We've built our organization as a drug discovery engine and
are focused on integrating all the
